litlas
ログインアカウント作成

Robert S. Rosenson

1993–2025 年に発表

別表記
Robert S Rosenson
181
論文数
26,424
被引用数
84
h 指数
171
i10 指数

被引用数

Robert S. Rosenson の年別被引用数1972 年: 被引用 1 件1979 年: 被引用 1 件1983 年: 被引用 1 件1985 年: 被引用 3 件1992 年: 被引用 1 件1995 年: 被引用 1 件1997 年: 被引用 1 件1998 年: 被引用 5 件1999 年: 被引用 23 件2000 年: 被引用 31 件2001 年: 被引用 44 件2002 年: 被引用 69 件2003 年: 被引用 51 件2004 年: 被引用 59 件2005 年: 被引用 66 件2006 年: 被引用 70 件2007 年: 被引用 66 件2008 年: 被引用 97 件2009 年: 被引用 105 件2010 年: 被引用 116 件2011 年: 被引用 131 件2012 年: 被引用 140 件2013 年: 被引用 177 件2014 年: 被引用 215 件2015 年: 被引用 198 件2016 年: 被引用 188 件2017 年: 被引用 194 件2018 年: 被引用 189 件2019 年: 被引用 688 件2020 年: 被引用 701 件2021 年: 被引用 863 件2022 年: 被引用 785 件2023 年: 被引用 611 件2024 年: 被引用 1,096 件2025 年: 被引用 813 件2026 年: 被引用 50 件1973〜1978 年は被引用が無いため表示していません1980〜1982 年は被引用が無いため表示していません1984 年は被引用が無いため表示していません1986〜1991 年は被引用が無いため表示していません1993〜1994 年は被引用が無いため表示していません1996 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,689 件、この内訳の 23.9%中国: 引用元論文 888 件、この内訳の 7.9%イギリス: 引用元論文 727 件、この内訳の 6.5%イタリア: 引用元論文 639 件、この内訳の 5.7%カナダ: 引用元論文 495 件、この内訳の 4.4%ドイツ: 引用元論文 458 件、この内訳の 4.1%オーストラリア: 引用元論文 409 件、この内訳の 3.6%フランス: 引用元論文 371 件、この内訳の 3.3%オランダ: 引用元論文 367 件、この内訳の 3.3%スペイン: 引用元論文 286 件、この内訳の 2.6%日本: 引用元論文 235 件、この内訳の 2.1%ポーランド: 引用元論文 217 件、この内訳の 1.9%
0%23.9%その他 30.7%

機関

分野

  • Medicine78%
  • Biochemistry, Genetics and Molecular Biology12.3%
  • Immunology and Microbiology3.4%
  • Nursing1%
  • Health Professions0.9%
  • Neuroscience0.7%
  • その他3.7%

トピック

  • Lipoproteins and Cardiovascular Health12.8%
  • Diabetes, Cardiovascular Risks, and Lipoproteins7.5%
  • Cancer, Lipids, and Metabolism3.2%
  • Atherosclerosis and Cardiovascular Diseases2.9%
  • Lipid metabolism and disorders2.4%
  • Pulmonary Hypertension Research and Treatments2.1%
  • その他69.1%

共著者

全論文

検索で開く
  1. Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease

    著者: Michelle L. O’Donoghue, Robert S. Rosenson, Bariş Gencer, J. Antonio G. López, Norman E. Lepor, Seth J. Baum, Elmer Stout, Daniel Gaudet, Beat Knüsel, Julia Kuder, Xinhui Ran, Sabina A. Murphy, Huei Wang, You Wu, Helina Kassahun, Marc S. Sabatine - New England Journal of Medicine 2022 被引用: 521

  2. Evinacumab for Homozygous Familial Hypercholesterolemia

    著者: Frederick J. Raal, Robert S. Rosenson, Laurens F. Reeskamp, G. Kees Hovingh, John J.P. Kastelein, Paolo Rubba, Shazia Ali, Poulabi Banerjee, Kuo‐Chen Chan, Daniel A. Gipe, Nagwa Khilla, Robert Pordy, David M. Weinreich, George D. Yancopoulos, Yi Zhang, Daniel Gaudet - New England Journal of Medicine 2020 被引用: 764

  3. Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia

    著者: Robert S. Rosenson, Daniel Gaudet, Robert A. Hegele, Christie M. Ballantyne, Stephen J. Nicholls, Kathryn J. Lucas, Javier San Martín, Rong Zhou, Ma'An Muhsin, Ting Chang, Jennifer Hellawell, Gerald F. Watts - New England Journal of Medicine 2024 被引用: 195

  4. Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia

    著者: Christie M. Ballantyne, Szilárd Vasas, Masoud Azizad, Peter Clifton, Robert S. Rosenson, Ting Chang, Stacey Melquist, Rong Zhou, Ma’an Mushin, Nicholas J. Leeper, Jennifer Hellawell, Daniel Gaudet - New England Journal of Medicine 2024 被引用: 191

  5. Deep learning for cardiovascular medicine: a practical primer

    著者: Chayakrit Krittanawong, Kipp W. Johnson, Robert S. Rosenson, Zhen Wang, Mehmet Aydar, Usman Baber, James K. Min, W.H. Wilson Tang, Jonathan L. Halperin, Sanjiv M. Narayan - European Heart Journal 2019 被引用: 411

  6. Plozasiran (ARO-APOC3) for Severe Hypertriglyceridemia

    著者: Daniel Gaudet, Dénes Páll, Gerald F. Watts, Stephen J. Nicholls, Robert S. Rosenson, Karen Modesto, Javier San Martín, Jennifer Hellawell, Christie M. Ballantyne - JAMA Cardiology 2024 被引用: 153

  7. Evinacumab in Patients with Refractory Hypercholesterolemia

    著者: Robert S. Rosenson, Lesley Burgess, Christoph Ebenbichler, Seth J. Baum, Erik S.G. Stroes, Shazia Ali, Nagwa Khilla, Robert L. Hamlin, Robert Pordy, Yuping Dong, Vladimir Son, Daniel Gaudet - New England Journal of Medicine 2020 被引用: 294

  8. Evinacumab in severe hypertriglyceridemia with or without lipoprotein lipase pathway mutations: a phase 2 randomized trial

    著者: Robert S. Rosenson, Daniel Gaudet, Christie M. Ballantyne, Seth J. Baum, Jean Bergeron, Erin E. Kershaw, Patrick M. Moriarty, Paolo Rubba, David C. Whitcomb, Poulabi Banerjee, Andrew Gewitz, Claudia Gonzaga‐Jauregui, Jennifer McGinniss, Manish P. Ponda, Robert Pordy, Jian Zhao, Daniel J. Rader - Nature Medicine 2023 被引用: 130

  9. Dysfunctional HDL and atherosclerotic cardiovascular disease

    著者: Robert S. Rosenson, H. Bryan Brewer, Benjamin J. Ansell, Philip J. Barter, M. John Chapman, Jay W. Heinecke, Anatol Kontush, Alan R. Tall, Nancy R. Webb - Nature Reviews Cardiology 2015 被引用: 800

  10. Use of Lipid-Lowering Therapies Over 2 Years in GOULD, a Registry of Patients With Atherosclerotic Cardiovascular Disease in the US

    著者: Christopher P. Cannon, James A. de Lemos, Robert S. Rosenson, Christie M. Ballantyne, Yuyin Liu, Qi Gao, Tamara Palagashvilli, Shushama Alam, Katherine E. Mues, Deepak L. Bhatt, Mikhail Kosiborod, GOULD Investigators, Thomas Knickelbine, Charles Augenbraun, James V. Talano, Faisal Wahid, David Suh, Ranchhod Khant, Shamaila Aslam, Scott Merryman, David M. Herrington, Philip Patel, Kenneth Fox, Sumant Lamba, Steven G. Brodie, Neil Sheth, Kahlid Sheikh, Allen Geltzer, Michael Lillestol, Kamlesh Dave, Stanley Koch, Steven Lupovitch, Carlos Piniella, Lawrence W. Allen, Rakesh M. Vohra, S Geller, Rohit Amin, Charles Michieli, Philip Levin, Nicolas W. Shammas, Andrew Potler, Vladimir Santos, Madaiah Revana, Ellis Lader, David J. Strobl, Megan A. Supple, Denes Korpas, Donna DeSantis, Debra Fuchs-Ertman, Wael Eid, Linda P Calhoun, Narendra Upadhyaya, Ryan Cotter, James J. Maciejko, Paul Ziajka, William Smith, Eduardo Antezano, Philip O Donnell, Lance Sloan, Vance Wilson, Denise Janosik, James J. Kmetzo, Sumana Gangi, Chrisette Dharma, D. Godkar, Philip Nicol, Micheal Hong, Catherine Popkin, Rajesh Patel, Abelardo Vargas, Minesh Patel, Vikas Desai, Yunsheng Ma, Robert Block, Louis Hiotis, Colby Grossman, Ahmed A. Arif, Seth J. Baum, Carlos Brown Sotolongo, Rebecca Jordan, Paul D. Thompson, Mark Napoli, Robert M. Davidson, Hugh Durrence, Karen Aspry, R Miller, David Headley, Richard Rothschild, Raymond Little, Carl Meisner, Richard Powell, Eliot Moon, Kul Aggarwal, Mark S. Turner, Idalia Acosta, Martin Schear, R. I. Harris, Robert Lending, Abraham Salacata, Vicki Kalen ほか 30 名 - JAMA Cardiology 2021 被引用: 225

  11. Machine learning-based marker for coronary artery disease: derivation and validation in two longitudinal cohorts

    著者: Iain S. Forrest, Ben Omega Petrazzini, Áine Duffy, Joshua K. Park, Carla Márquez‐Luna, Daniel M. Jordan, Ghislain Rocheleau, Judy H. Cho, Robert S. Rosenson, Jagat Narula, Girish N. Nadkarni, Ron Do - The Lancet 2022 被引用: 162

  12. Cholesterol Efflux and Atheroprotection

    著者: Robert S. Rosenson, H. Bryan Brewer, W. Sean Davidson, Zahi A. Fayad, Valentı́n Fuster, James Goldstein, Marc K. Hellerstein, Xian‐Cheng Jiang, Michael C. Phillips, Daniel J. Rader, Alan T. Remaley, George H. Rothblat, Alan R. Tall, Laurent Yvan‐Charvet - Circulation 2012 被引用: 952

  13. Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk

    著者: Gerald F. Watts, Robert S. Rosenson, Robert A. Hegele, Ira J. Goldberg, Antonio Gallo, Ann C. Mertens, Alexis Baass, Rong Zhou, Ma'An Muhsin, Jennifer Hellawell, Nicholas J. Leeper, Daniel Gaudet - New England Journal of Medicine 2024 被引用: 152

  14. The Evolving Future of PCSK9 Inhibitors

    著者: Robert S. Rosenson, Robert A. Hegele, Sergio Fazio, Christopher P. Cannon - Journal of the American College of Cardiology 2018 被引用: 264

  15. Efficacy and Safety of Alirocumab in Adults With Homozygous Familial Hypercholesterolemia

    著者: Dirk Blom, Mariko Harada‐Shiba, Paolo Rubba, Daniel Gaudet, John J.P. Kastelein, Min‐Ji Charng, Robert Pordy, Stephen Donahue, Shazia Ali, Yuping Dong, Nagwa Khilla, Poulabi Banerjee, Marie T. Baccara‐Dinet, Robert S. Rosenson - Journal of the American College of Cardiology 2020 被引用: 165

  16. Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance

    著者: Steven E. Nissen, Erik S.G. Stroes, Ricardo E. Dent‐Acosta, Robert S. Rosenson, Sam J. Lehman, Naveed Sattar, David Preiss, Éric Bruckert, R Češka, Norman E. Lepor, Christie M. Ballantyne, Ioanna Gouni-Berthold, Mary Elliott, Danielle M. Brennan, Scott M. Wasserman, Ransi Somaratne, Rob Scott, Evan A. Stein, for the GAUSS-3 Investigators - JAMA 2016 被引用: 511

  17. Clinical Trial Design for Lipoprotein(a)-Lowering Therapies

    著者: Waqas Malick, Sascha N. Goonewardena, Wolfgang Köenig, Robert S. Rosenson - Journal of the American College of Cardiology 2023 被引用: 92

  18. Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials

    著者: Paul Guedeney, Gennaro Giustino, Sabato Sorrentino, Bimmer E. Claessen, Anton Camaj, Deborah N. Kalkman, Birgit Vogel, Samantha Sartori, Salvatore De Rosa, Usman Baber, Ciro Indolfi, Gilles Montalescot, George Dangas, Robert S. Rosenson, Stuart Pocock, Roxana Mehran - European Heart Journal 2019 被引用: 201

  19. Primary Prevention of Subclinical Atherosclerosis in Young Adults

    著者: Ana Devesa, Borja Ibáñez, Waqas Malick, Elizabeth Tinuoye, Jessica Bustamante, Carlos Peyra, Robert S. Rosenson, Deepak L. Bhatt, Gregg W. Stone, Valentı́n Fuster - Journal of the American College of Cardiology 2023 被引用: 74

  20. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.

    著者: Lawler, Patrick R, Goligher, Ewan C, Berger, Jeffrey S, Patrick R. Lawler, Ewan C. Goligher, Jeffrey S. Berger, Matthew D. Neal, Bryan J. McVerry, José Carlos Nicolau, Michelle N. Gong, Marc Carrier, Robert S Rosenson, Harmony R. Reynolds, Alexis F. Turgeon, Jorge Escobedo, David T. Huang, Charlotte Bradbury, Brett L. Houston, Lucy Z. Kornblith, Anand Kumar, Susan R. Kahn, Mary Cushman, Zoe McQuilten, Arthur S. Slutsky, Keri S. Kim, Anthony Gordon, Bridget‐Anne Kirwan, Maria M. Brooks, Alisa M. Higgins, Roger Lewis, Elizabeth Lorenzi, Scott Berry, Lindsay R. Berry, Aaron W. Aday, Farah Al-Beidh, Djillali Annane, Yaseen M. Arabi, Diptesh Aryal, Bihari, Shailesh, Abi Beane, Zahra Bhimani, Shailesh Bihari, Henny H. Billett, Lindsay Bond, Marc J. M. Bonten, Frank Brunkhorst, Meredith Buxton, Adrian Buzgau, Lana A. Castellucci, Sweta Chekuri, Jen‐Ting Chen, Allen Cheng, Tamta Chkhikvadze, Benjamin Coiffard, Todd W. Costantini, Sophie de Brouwer, Lennie Derde, Michelle A. Detry, Abhijit Duggal, Vladimír Džavík, Mark B. Effron, Lise J Estcourt, Brendan M. Everett, Dean Fergusson, Mark Fitzgerald, Robert Fowler, J.‐P. Galanaud, Benjamin Galen, Sheetal Gandotra, Sebastián García‐Madrona, Timothy D. Girard, Lucas C. Godoy, Andrew L. Goodman, Herman Goossens, Cameron Green, Yonatan Greenstein, Peter L Gross, Naomi M. Hamburg, Rashan Haniffa, George P. Hanna, Nicholas Hanna, Sheila M. Hegde, Carolyn M. Hendrickson, R. Duncan Hite, Alexander Hindenburg, Aluko A. Hope, James M Horowitz, Christopher M. Horvat, Kristin Hudock, Beverley J. Hunt, Mansoor Husain, Robert C. Hyzy, Vivek Iyer, Jeffrey R. Jacobson, Devachandran Jayakumar, Norma Keller, Akram Khan, Yuri Kim, Andrei Kindzelski, Andrew J. King ほか 78 名 - 2021 被引用: 589

  21. HDL Measures, Particle Heterogeneity, Proposed Nomenclature, and Relation to Atherosclerotic Cardiovascular Events

    著者: Robert S. Rosenson, H. Bryan Brewer, M. John Chapman, Sergio Fazio, M. Mahmood Hussain, Anatol Kontush, Ronald M. Krauss, James D. Otvos, Alan T. Remaley, Ernst J. Schaefer - Clinical Chemistry 2011 被引用: 513

  22. Varespladib and Cardiovascular Events in Patients With an Acute Coronary Syndrome

    著者: Stephen J. Nicholls, John J.P. Kastelein, Gregory G. Schwartz, Dianna Bash, Robert S. Rosenson, Matthew A. Cavender, Danielle M. Brennan, Wolfgang Köenig, J. Wouter Jukema, Vijay Nambi, R. Scott Wright, Venu Menon, A. Michael Lincoff, Steven E. Nissen - JAMA 2014 被引用: 340

  23. Evinacumab, an ANGPTL3 Inhibitor, in the Treatment of Dyslipidemia

    著者: Bożena Sosnowska, Weronika Adach, Stanisław Surma, Robert S. Rosenson, Maciej Banach - Journal of Clinical Medicine 2022 被引用: 49

  24. New Therapies for Lowering Triglyceride-Rich Lipoproteins

    著者: Robert S. Rosenson, Aleesha Shaik, Wen‐Liang Song - Journal of the American College of Cardiology 2021 被引用: 61